Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesMorphine Glucuronidation in Preterm Neonates, Infants and Children Younger than 3 Years
Clinical Pharmacokinetics, 08/19/09
Knibbe CAJ et al. – Model–based simulations show that in newborns, including preterms, infants and children under the age of 3 years, a loading dose in micro g/kg and a maintenance dose expressed in micro g/kg1.5/h, with a 50% reduction of the maintenance dose in newborns younger than 10 days, results in a narrow range of morphine and metabolite serum concentrations throughout the studied age range.
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Predicting short term response to anti-inflammatory therapy in young children with asthma
Current Medical Research and Opinion, 12/17/09
Dienogest: a new therapeutic agent for the treatment of endometriosis *TEST*
Women's Health, 12/17/09
Investigational drugs for allergic rhinitis
Expert Opinion on Investigational Drugs, 12/17/09
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome
Current Medical Research and Opinion, 12/17/09
vancomycinpharmacokinetic–pharmacodynamic properties in the treatment of MRSA infections
Expert Review of Anti-infective Therapy, 12/17/09
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia
Leukemia and Lymphoma, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor